Top Markets
Coin of the day
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Pozycja w akcjach #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Cena akcji
$45.79
Kapitalizacja rynkowa
$2.33B
Zmiana (1 dzień)
11.43%
Zmiana (1 rok)
408.10%
Kraj
FR
Handel Nanobiotix S.A. (NANO)

Kategoria

Historia ceny akcji dla Nanobiotix S.A. (NANO)
Najwyższa cena zamknięcia: $41.65 dnia 2026-08-01

Najniższa cena zamknięcia: $8.60 dnia 2012-10-01
Historia cen akcji firmy Nanobiotix S.A. od 2012 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 29.51%
2025 582.51%
2024 -45.85%
2023 51.22%
2022 -50.99%
2021 -50.84%
2020 93.52%
2019 -37.58%
2018 -11.94%
2017 -7.30%
2016 -2.69%
2015 -15.40%
2014 172.96%
2013 -14.45%
2012 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$549.16 41.14%
US
$1.06K 49.18%
NL
$122.63 -12.65%
AU
$142.75 468.71%
US
$765.25 7.19%
CH